In adults with type 2 diabetes and chronic kidney disease, taking a weekly dose of semaglutide at 1.0 mg is associated with a 20% lower risk of dying from any cause compared to taking a placebo over...
Mechanism
Synthesis from 1 study
Semaglutide helps the body control blood sugar better, lose weight, and reduces stress on the heart and kidneys. This makes it less likely for these organs to fail or cause life-threatening problems over time.
Most probable mechanism
Semaglutide helps the body use insulin better, lowers blood sugar and blood pressure, and reduces fat buildup in organs like the kidneys and heart. This lessens stress on these organs and lowers the chance they fail or cause deadly complications.
Semaglutide activates glucagon-like peptide-1 (GLP-1) receptors in pancreatic beta cells, enhancing glucose-dependent insulin secretion and suppressing glucagon release.
Improved glycemic control reduces hyperglycemia-induced oxidative stress and advanced glycation end-product formation in vascular and renal tissues.
Semaglutide promotes weight loss and reduces ectopic fat deposition in the liver and kidneys, improving organ function.
Reduced systemic inflammation and endothelial dysfunction occur due to lower levels of pro-inflammatory cytokines and improved vascular tone.
Slowed progression of diabetic kidney disease and reduced cardiac strain lower the incidence of fatal events such as cardiovascular collapse, sepsis, or acute renal failure.
Evidence from Studies
Supporting (1)
Community contributions welcome
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.